drugset / Trial / NCT04805060
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors
NaSequentialOpen-labelTreatment
Summary
This study is a phase I study to evaluate the safety and tolerability of TQB2858 injection in patients with advanced malignancy.
Timeline
- Start
- 2021-04-23
- Primary completion
- 2021-12-12
- Completion
- 2025-12-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TQB2858 | Protein / enzyme biologic | — | Intravenous |